Rigel Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsRigel Pharmaceuticals

Rigel Pharmaceuticals(RIGL)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Tavalisse	Fostamatinib	2018-04-17	2026-2032	Thrombocytopenia
Rezlidhia	Olutasidenib	2022-12-01	2035-2039	Myeloid leukemia acute
Gavreto	Pralsetinib	2020-09-04	2036-2039	Non-small-cell lung carcinoma

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

pharmacokinetics

,

drug interactions

,

ovarian neoplasms

,

hematologic neoplasms

,

renal insufficiency

,

,

hepatic insufficiency

,

biological availability

,

,

myelodysplastic syndromes

,

myelomonocytic leukemia chronic

,

myelomonocytic leukemia acute

,

myelomonocytic leukemia juvenile

,

,

,

sickle cell anemia

,

sickle cell trait

,

pancreatic ductal carcinoma

,

pancreatic neoplasms

,

lung transplantation

,

thrombocytopenia

,

,

graft vs host disease

,

bronchiolitis obliterans syndrome

,

kidney diseases

,

iga glomerulonephritis

,

,

primary myelofibrosis

,

kidney transplantation

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

renal cell carcinoma

,

,

colorectal neoplasms

,

,

non-small-cell lung carcinoma

,

head and neck neoplasms

,

pheochromocytoma

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

systemic lupus erythematosus

,

hidradenitis suppurativa

,

,

,

respiratory distress syndrome

,

rheumatoid arthritis

,

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

,

coronavirus infections

,

,

hemolytic anemia autoimmune

,

,

,

,

hemolytic anemia

,

,

communicable diseases

,

severe acute respiratory syndrome

,

viral pneumonia

erectile dysfunction

respiratory tract infections

,

Globulin, immune

,

systemic scleroderma

,

diffuse scleroderma

,

anti-neutrophil cytoplasmic antibody-associated vasculitis

discoid lupus erythematosus

,

systemic lupus erythematosus

allergic rhinitis

,

,

allergic rhinitis seasonal

healthy volunteers/patients

,

rheumatoid arthritis

,

,

,

,

thrombocytopenic purpura idiopathic

,

,

photosensitivity disorders

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

multiple myeloma

,

plasma cell neoplasms

,

rheumatoid arthritis

,

,

,

chronic hepatitis c

,

chronic hepatitis b

,

,

chronic hepatitis

,

,

,

anxiety disorders

,

,

,

,

,

,

acquired immunodeficiency syndrome

,

communicable diseases

,

,

immunologic deficiency syndromes

,

inflammatory breast neoplasms

,

atrial fibrillation

,

macular degeneration

,

,

pulmonary tuberculosis

,

,

,

thrombocytopenia

,

non-small-cell lung carcinoma

,

,

systemic lupus erythematosus

,

,

,

,

diabetes mellitus

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

atherosclerosis

,

ovarian neoplasms

,

endometrial neoplasms

,

ovarian epithelial carcinoma

,

respiratory syncytial viruses

,

breast neoplasms

,

,

postmenopausal osteoporosis

,

alzheimer disease

,

personal satisfaction

,

hypersensitivity

,

dentin sensitivity

,

tension-type headache

,

,

,

prostatic hyperplasia

,

,

,

,

,

,

,

,

spinal cord injuries

,

erectile dysfunction

,

,

chronic obstructive pulmonary disease

,

,

migraine disorders

,

type 2 diabetes mellitus

,

,

prostatic neoplasms

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use